JUBLINGREA fundamentals

Key facts

Market capitalization‪102.86 B‬INR
Founded2019
Employees (FY)‪3.56 K‬
CEODeepak Jain
About

Jubilant Ingrevia Ltd. engages in the provision of life science products and solutions. The company operates through the following segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The Speciality Chemicals segment manufactures pyridine and picolines, fine chemicals, and agro chemicals. The Nutrition and Health Solutions segment offers nutrition and health ingredients, as well as animal and human nutrition health solutions. The Life Science Chemicals segment includes acetyls and specialty ethanol. The company was founded in 2019 and is headquartered in Noida, India.

Ownership
‪‪159.28 M‬‬
Closely held shares
‪‪90.02 M‬‬ (56.52%)
Free Float shares
‪‪69.26 M‬‬ (43.48%)
Closely held shares
‪‪90.02 M‬‬ (56.52%)
Free Float shares
‪‪69.26 M‬‬ (43.48%)
Capital structure
Market cap
‪‪102.86 B‬‬
Enterprise value
‪‪102.86 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪102.86 B‬‬
Price to earning ratio (P/E)
49.51x
Price to sales ratio (P/S)
2.43x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
49.51x
Price to sales ratio (P/S)
2.43x
Valuation ratios
‪0.00‬
‪0.80‬
‪1.60‬
‪2.40‬
‪3.20‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪20.00‬
‪40.00‬
‪60.00‬
‪80.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪2.5%‬
‪3.6%‬
‪4.7%‬
‪5.8%‬
‪6.9%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Chemical Intermediates
Speciality Chemicals
Nutrition & Health Solutions
By country
Period: 2023
India
Americas and Europe
Rest of the World
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Actual
Estimate
Earnings
Next:May 13, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪1.10‬
‪2.20‬
‪3.30‬
‪4.40‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
38.37%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.77%
Last payment
2.50
Last ex-date
Feb 3, 2025
Dividend history
‪0.10%‬
‪0.45%‬
‪0.80%‬
‪1.15%‬
‪1.50%‬
2020
2021
2022
2023
‪0.00‬
‪1.30‬
‪2.60‬
‪3.90‬
‪5.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities